Every year, thousands of people are harmed because two drugs look or sound too much like each other. It’s not a rare glitch. It’s a systemic problem, and it’s happening most often with generic drugs. You might think generics are just cheaper versions of brand-name pills - and they are. But what you don’t see is how easily a pharmacist, nurse, or even a doctor can mix them up. The names are too similar. The pills look too much alike. And when that happens, the wrong drug can end up in the wrong patient - with life-threatening results.
What Are Look-Alike, Sound-Alike (LASA) Drugs?
Look-alike, sound-alike (LASA) drugs are medications that either look similar in packaging, shape, or color, or sound alike when spoken aloud. These aren’t just minor mix-ups. They’re dangerous. Take hydralazine and a blood pressure medication used to treat hypertension and hydroxyzine and an antihistamine used for anxiety and itching. The names are almost identical. The capsules are both small, white, and round. One is meant to lower blood pressure. The other calms nerves. Give the wrong one to a patient, and you could cause a stroke, a severe allergic reaction, or even death.
Sound-alike errors happen when names are spoken - especially during busy shifts. Think of quinidine and a heart rhythm drug versus quinine and a malaria treatment. Say them out loud. They’re nearly indistinguishable. In a hospital hallway, over a crackling intercom, or during a handoff between shifts, that’s all it takes.
Why Generics Make It Worse
Brand-name drugs usually have unique packaging and clear branding. But generics? They’re made by dozens of manufacturers. Each one uses slightly different colors, fonts, or pill shapes. But not enough to stand out. A 2021 study in Pharmacy Practice found that over 10% of medication errors were directly tied to how similar the pills looked. That’s not a coincidence. It’s a design flaw.
Take Valtrex and an antiviral for herpes versus Valcyte and an antiviral for CMV in transplant patients. Both start with "Val-", both are used in immunocompromised patients, and both come in similar-sized tablets. The brand names are confusing. But when generic versions of both are on the shelf? The risk multiplies. Pharmacists don’t even have to make a mistake. The packaging does it for them.
The Numbers Don’t Lie
The World Health Organization says LASA errors cause about 25% of all medication mistakes worldwide. That’s one in four. In the UK alone, between July 2018 and June 2019, over 206,000 medication incidents were reported. Of those, 66 people died. Many were linked to name confusion.
And it’s not just hospitals. A 2021 survey of pharmacists found that 78% had encountered a LASA error at least once a month. Over a third saw near-misses every week. Nurses in intensive care units report hearing "dopamine" and "dobutamine" confused during verbal orders - two heart drugs with wildly different effects. One increases blood pressure. The other improves heart pumping. Mix them up, and you could kill someone.
How We’re Trying to Fix It
There are proven ways to cut these errors - and some are already working.
- Tall man lettering - using capital letters to highlight differences: predniSONE vs. predniSOLONE. This simple trick reduced errors by 67% in a 12-hospital system.
- Physical separation - keeping high-risk LASA drugs on different shelves. No more side-by-side storage of hydralazine and hydroxyzine.
- Barcode scanning + alerts - when a pharmacist scans a drug, the system checks for similar names and warns them. One hospital cut LASA errors by 45% using this method.
- AI in EHRs - a 2023 study showed AI systems flagged 98.7% of potential LASA errors with only 1.3% false alarms. That’s game-changing.
The U.S. FDA rejected 34 new drug names in 2021 just because they were too similar to existing ones. The European Medicines Agency now requires all new drugs to pass a name-similarity check. That’s progress.
What Still Isn’t Being Done
But here’s the problem: most hospitals still don’t use these tools. A 2023 survey found that Magnet-recognized hospitals - the ones with the highest nursing standards - use an average of 6.2 LASA prevention strategies. Non-Magnet hospitals? Just 2.4. That gap isn’t about money. It’s about culture. Too many still treat these errors as "human mistakes," not system failures.
And generics? They’re still not held to a standard for packaging design. One manufacturer’s hydroxyzine pill might be blue. Another’s is white. No one enforces consistency. That’s why the same drug can look completely different depending on where you buy it.
What You Can Do
If you take generics - and most people do - here’s how to protect yourself:
- Always check the pill’s shape, color, and imprint. If it looks different from last time, ask your pharmacist why.
- Ask: "What is this for?" If the answer doesn’t match what your doctor told you, pause.
- Use one pharmacy. That way, your records stay consistent, and pharmacists know your history.
- Keep a list of all your meds - including the generic names - and bring it to every appointment.
Doctors and pharmacists aren’t careless. They’re overworked. The system is broken. But you’re not powerless. You’re the last line of defense.
What’s Next?
The WHO’s "Medication Without Harm" goal aims to cut severe medication errors by 50% by 2025. That’s doable - if we stop treating LASA errors as unavoidable. We know how to fix them. We’ve seen the data. We’ve seen the results. What’s missing is the will.
Until packaging standards are enforced globally. Until AI alerts are mandatory in every EHR. Until every pharmacy stops storing similar drugs side by side - this will keep happening. And people will keep getting hurt.
Are look-alike, sound-alike errors only a problem in hospitals?
No. While hospitals report the most incidents, these errors happen everywhere - in clinics, nursing homes, and even community pharmacies. A patient might get the wrong generic version of a drug because the pharmacist grabbed the wrong bottle off the shelf. Or a doctor might prescribe a drug that sounds like another one during a rushed phone call. LASA errors don’t care where they happen. They just care that the names are too similar.
Why don’t drug companies change the names to avoid confusion?
They do - but only for new drugs. The FDA and EMA now reject names that are too similar to existing ones. But thousands of older drugs - especially generics - are already on the market. Changing their names would mean rebranding, retraining, and relabeling millions of pills. It’s expensive. So the system leaves them as-is, even if they’re risky. That’s why the problem keeps growing.
Do all generic versions of the same drug look the same?
No. Unlike brand-name drugs, which have consistent packaging, generic manufacturers can use different colors, shapes, and imprints. Two pills with the same active ingredient might look completely different depending on who made them. That’s why it’s so important to check your pill each time you refill - even if the name hasn’t changed.
Can tall man lettering really prevent errors?
Yes. Studies show it reduces errors by up to 67%. When "predniSONE" is written with capital S’s, it’s easier to distinguish from "predniSOLONE" - especially on handwritten prescriptions or computer screens. It’s a simple, low-cost fix that’s been proven to work. Yet many pharmacies still don’t use it.
Is it safe to switch between generic brands?
For most drugs, yes. But for drugs with narrow therapeutic windows - like blood thinners, seizure meds, or thyroid drugs - even small differences in absorption can matter. If you switch brands and notice new side effects, tell your doctor. Also, if the pill looks different, ask if it’s the same medication. Don’t assume.